Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Vamotinib

Vamotinib
Vamotinib (PF-114) is an orally active and specific tyrosine kinase inhibitor with antiproliferative and antitumour activity.Vamotinib inhibits the phosphorylation of BCR/ABL and BCR/ABL-T315I, which promotes apoptosis. Vamotinib is used to study drug-resistant Philadelphia chromosome-positive (Ph+) leukaemia and Alzheimer's disease.
Catalog No. T63746Cas No. 1416241-23-0
Select Batch
Purity:99.34%
Contact us for more batch information
Resource Download

Vamotinib

Catalog No. T63746Cas No. 1416241-23-0
Vamotinib (PF-114) is an orally active and specific tyrosine kinase inhibitor with antiproliferative and antitumour activity.Vamotinib inhibits the phosphorylation of BCR/ABL and BCR/ABL-T315I, which promotes apoptosis. Vamotinib is used to study drug-resistant Philadelphia chromosome-positive (Ph+) leukaemia and Alzheimer's disease.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Pack SizePriceAvailabilityQuantity
1 mg$133In Stock
2 mg$196In Stock
5 mg$328In Stock
10 mg$538In Stock
25 mg$1,080In Stock
50 mg$1,730In Stock
100 mg$2,780In Stock
1 mL x 10 mM (in DMSO)$388In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Vamotinib"

Product Introduction

Bioactivity
Description
Vamotinib (PF-114) is an orally active and specific tyrosine kinase inhibitor with antiproliferative and antitumour activity.Vamotinib inhibits the phosphorylation of BCR/ABL and BCR/ABL-T315I, which promotes apoptosis. Vamotinib is used to study drug-resistant Philadelphia chromosome-positive (Ph+) leukaemia and Alzheimer's disease.
Targets&IC50
Abl (F317I):2.0 nM, Abl (T315I):0.78 nM, Abl (Y253F):4.1 nM, Abl (E255K):9.5 nM, BCR-ABL:0.49 nM, Abl (G250E):7.4 nM, Abl (H396P):1.0 nM, Abl (Q252H):12 nM
In vitro
Vamotinib (0-1000 nM) inhibits the autophosphorylation of BCR/ABL and BCR/ABL-T315I in a dose-dependent manner. Additionally, it can suppress the growth of Ph+ patient-derived cell lines, including K562, KCL-22, SupB15, Tom-1, BV-173, as well as Ph+ PD-LTC cells with non-mutated resistance and T315I mutation[1].
In vivo
In female BALB/cAnNRj-Foxn1nu mice (K562 nude mouse xenograft model), Vamotinib (25/40 mg/kg, oral gavage; 14 days) resulted in a 100% reduction in average tumor volume within 4 weeks.
AliasPF-114
Chemical Properties
Molecular Weight532.56
FormulaC29H27F3N6O
Cas No.1416241-23-0
Storage & Solubility Information
Storagekeep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 30 mg/mL (56.33 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.8777 mL9.3886 mL18.7772 mL93.8861 mL
5 mM0.3755 mL1.8777 mL3.7554 mL18.7772 mL
10 mM0.1878 mL0.9389 mL1.8777 mL9.3886 mL
20 mM0.0939 mL0.4694 mL0.9389 mL4.6943 mL
50 mM0.0376 mL0.1878 mL0.3755 mL1.8777 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Vamotinib | purchase Vamotinib | Vamotinib cost | order Vamotinib | Vamotinib chemical structure | Vamotinib in vivo | Vamotinib in vitro | Vamotinib formula | Vamotinib molecular weight